Literature DB >> 23797369

Right ventricular dysfunction in systemic sclerosis-associated pulmonary arterial hypertension.

Ryan J Tedford, James O Mudd, Reda E Girgis, Stephen C Mathai, Ari L Zaiman, Traci Housten-Harris, Danielle Boyce, Benjamin W Kelemen, Anita C Bacher, Ami A Shah, Laura K Hummers, Fredrick M Wigley, Stuart D Russell, Rajeev Saggar, Rajan Saggar, W Lowell Maughan, Paul M Hassoun, David A Kass.   

Abstract

BACKGROUND: Systemic sclerosis–associated pulmonary artery hypertension (SScPAH) has a worse prognosis compared with idiopathic pulmonary arterial hypertension (IPAH), with a median survival of 3 years after diagnosis often caused by right ventricular (RV) failure. We tested whether SScPAH or systemic sclerosis–related pulmonary hypertension with interstitial lung disease imposes a greater pulmonary vascular load than IPAH and leads to worse RV contractile function. METHODS AND
RESULTS: We analyzed pulmonary artery pressures and mean flow in 282 patients with pulmonary hypertension (166 SScPAH, 49 systemic sclerosis–related pulmonary hypertension with interstitial lung disease, and 67 IPAH). An inverse relation between pulmonary resistance and compliance was similar for all 3 groups, with a near constant resistance×compliance product. RV pressure–volume loops were measured in a subset, IPAH (n=5) and SScPAH (n=7), as well as SSc without PH (n=7) to derive contractile indexes (end-systolic elastance [Ees] and preload recruitable stroke work [Msw]), measures of RV load (arterial elastance [Ea]), and RV pulmonary artery coupling (Ees/Ea). RV afterload was similar in SScPAH and IPAH (pulmonary vascular resistance=7.0±4.5 versus 7.9±4.3 Wood units; Ea=0.9±0.4 versus 1.2±0.5 mm Hg/mL; pulmonary arterial compliance=2.4±1.5 versus 1.7±1.1 mL/mm Hg; P>0.3 for each). Although SScPAH did not have greater vascular stiffening compared with IPAH, RV contractility was more depressed (Ees=0.8±0.3 versus 2.3±1.1, P<0.01; Msw=21±11 versus 45±16, P=0.01), with differential RV-PA uncoupling (Ees/Ea=1.0±0.5 versus 2.1±1.0; P=0.03). This ratio was higher in SSc without PH (Ees/Ea=2.3±1.2; P=0.02 versus SScPAH).
CONCLUSIONS: RV dysfunction is worse in SScPAH compared with IPAH at similar afterload, and may be because of intrinsic systolic function rather than enhanced pulmonary vascular resistive and pulsatile loading.

Entities:  

Mesh:

Year:  2013        PMID: 23797369      PMCID: PMC3815697          DOI: 10.1161/CIRCHEARTFAILURE.112.000008

Source DB:  PubMed          Journal:  Circ Heart Fail        ISSN: 1941-3289            Impact factor:   8.790


  41 in total

1.  Hemodynamic predictors of survival in scleroderma-related pulmonary arterial hypertension.

Authors:  Aránzazu Campo; Stephen C Mathai; Jérôme Le Pavec; Ari L Zaiman; Laura K Hummers; Danielle Boyce; Traci Housten; Hunter C Champion; Noah Lechtzin; Fredrick M Wigley; Reda E Girgis; Paul M Hassoun
Journal:  Am J Respir Crit Care Med       Date:  2010-03-25       Impact factor: 21.405

2.  Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study.

Authors:  Eric Hachulla; Virginie Gressin; Loïc Guillevin; Patrick Carpentier; Elisabeth Diot; Jean Sibilia; André Kahan; Jean Cabane; Camille Francès; David Launay; Luc Mouthon; Yannick Allanore; Kiet Phong Tiev; Pierre Clerson; Pascal de Groote; Marc Humbert
Journal:  Arthritis Rheum       Date:  2005-12

3.  Right ventricular preload recruitable stroke work, end-systolic pressure-volume, and dP/dtmax-end-diastolic volume relations compared as indexes of right ventricular contractile performance in conscious dogs.

Authors:  M K Karunanithi; J Michniewicz; S E Copeland; M P Feneley
Journal:  Circ Res       Date:  1992-06       Impact factor: 17.367

4.  Disproportionate elevation of N-terminal pro-brain natriuretic peptide in scleroderma-related pulmonary hypertension.

Authors:  S C Mathai; M Bueso; L K Hummers; D Boyce; N Lechtzin; J Le Pavec; A Campo; H C Champion; T Housten; P R Forfia; A L Zaiman; F M Wigley; R E Girgis; P M Hassoun
Journal:  Eur Respir J       Date:  2009-07-30       Impact factor: 16.671

5.  Use of pulse pressure method for estimating total arterial compliance in vivo.

Authors:  N Stergiopulos; P Segers; N Westerhof
Journal:  Am J Physiol       Date:  1999-02

6.  Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL).

Authors:  Raymond L Benza; Dave P Miller; Mardi Gomberg-Maitland; Robert P Frantz; Aimee J Foreman; Christopher S Coffey; Adaani Frost; Robyn J Barst; David B Badesch; C Gregory Elliott; Theodore G Liou; Michael D McGoon
Journal:  Circulation       Date:  2010-06-28       Impact factor: 29.690

7.  Disturbed right ventricular diastolic function in patients with systemic sclerosis: a Doppler tissue imaging study.

Authors:  Per Lindqvist; Kenneth Caidahl; Grete Neuman-Andersen; Cecilia Ozolins; Solbritt Rantapää-Dahlqvist; Anders Waldenström; Elsadig Kazzam
Journal:  Chest       Date:  2005-08       Impact factor: 9.410

8.  Influence of coronary occlusion during PTCA on end-systolic and end-diastolic pressure-volume relations in humans.

Authors:  D A Kass; M Midei; J Brinker; W L Maughan
Journal:  Circulation       Date:  1990-02       Impact factor: 29.690

9.  Assessment of right ventricular contractile state with the conductance catheter technique in the pig.

Authors:  M L Dickstein; O Yano; H M Spotnitz; D Burkhoff
Journal:  Cardiovasc Res       Date:  1995-06       Impact factor: 10.787

10.  Aortic stiffness in systemic sclerosis is increased independently of the extent of skin involvement.

Authors:  I Moyssakis; E Gialafos; V Vassiliou; E Taktikou; C Katsiari; D P Papadopoulos; P P Sfikakis
Journal:  Rheumatology (Oxford)       Date:  2004-11-16       Impact factor: 7.580

View more
  76 in total

Review 1.  The right ventricle and pulmonary hypertension.

Authors:  Mariëlle C van de Veerdonk; Harm J Bogaard; Norbert F Voelkel
Journal:  Heart Fail Rev       Date:  2016-05       Impact factor: 4.214

Review 2.  Physiology of the pulmonary circulation and the right heart.

Authors:  Robert Naeije
Journal:  Curr Hypertens Rep       Date:  2013-12       Impact factor: 5.369

3.  Independence Day: Separating Right Ventricular Function From Pulmonary Arterial Hypertension in Systemic Sclerosis.

Authors:  Bradley A Maron
Journal:  Circulation       Date:  2016-05-11       Impact factor: 29.690

4.  Right Ventricular Functional Reserve in Pulmonary Arterial Hypertension.

Authors:  Steven Hsu; Brian A Houston; Emmanouil Tampakakis; Anita C Bacher; Parker S Rhodes; Stephen C Mathai; Rachel L Damico; Todd M Kolb; Laura K Hummers; Ami A Shah; Zsuzsanna McMahan; Celia P Corona-Villalobos; Stefan L Zimmerman; Fredrick M Wigley; Paul M Hassoun; David A Kass; Ryan J Tedford
Journal:  Circulation       Date:  2016-05-11       Impact factor: 29.690

5.  Effect of acute arteriolar vasodilation on capacitance and resistance in pulmonary arterial hypertension.

Authors:  John H Newman; Evan L Brittain; Ivan M Robbins; Anna R Hemnes
Journal:  Chest       Date:  2015-04       Impact factor: 9.410

Review 6.  Assessment of right ventricular function in pulmonary hypertension.

Authors:  Robert Naeije
Journal:  Curr Hypertens Rep       Date:  2015-05       Impact factor: 5.369

7.  Moving in the "right" direction: exposing subclinical right ventricular disease with exercise in patients with systemic sclerosis.

Authors:  Sarah Hale; Benjamin H Freed
Journal:  Int J Cardiovasc Imaging       Date:  2021-05-17       Impact factor: 2.357

8.  Know Your Limitations: Assumptions in the Single-Beat Method for Estimating Right Ventricular-Pulmonary Vascular Coupling.

Authors:  Jennifer L Philip; Naomi C Chesler
Journal:  Am J Respir Crit Care Med       Date:  2018-09-15       Impact factor: 21.405

9.  Pulmonary Arterial Compliance in Acute Respiratory Distress Syndrome: Clinical Determinants and Association With Outcome From the Fluid and Catheter Treatment Trial Cohort.

Authors:  Thomas S Metkus; Emmanouil Tampakakis; Christopher J Mullin; Brian A Houston; Todd M Kolb; Stephen C Mathai; Rachel Damico; Bradley A Maron; Paul M Hassoun; Roy G Brower; Ryan J Tedford
Journal:  Crit Care Med       Date:  2017-03       Impact factor: 7.598

Review 10.  World Health Organization Group I Pulmonary Hypertension: Epidemiology and Pathophysiology.

Authors:  Kurt W Prins; Thenappan Thenappan
Journal:  Cardiol Clin       Date:  2016-08       Impact factor: 2.213

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.